SPS
ANAB icon

Susquehanna Portfolio Strategies’s AnaptysBio ANAB Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$330K Sell
4,882
-31,066
-86% -$1.88M 0.01% 734
2026
Q1 		$1.99M Hold
35,948
– – 0.03% 496
2025
Q4 		$1.74M Buy
35,948
+500
+1% +$19.5K 0.03% 527
2025
Q3 		$1.09M Buy
35,448
+2,645
+8% +$60.7K 0.02% 664
2025
Q2 		$728K Buy
+32,803
New +$687K 0.02% 580

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Susquehanna Portfolio Strategies's ANAB Position: Q2 2026 in Review

Susquehanna Portfolio Strategies reduced its AnaptysBio (ANAB) stake by 86% in Q2 2026, selling an estimated $1.88M and leaving 4,882 shares worth $330K. The position accounts for 0.01% of the portfolio, ranked #734.

Susquehanna Portfolio Strategies first reported a position in ANAB in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.99M in Q1 2026. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Susquehanna Portfolio Strategies held 4,882 shares of AnaptysBio worth $330K as of Q2 2026.
  • Susquehanna Portfolio Strategies sold 31,066 AnaptysBio shares in Q2 2026, an estimated $1.88M.
  • AnaptysBio made up 0.01% of Susquehanna Portfolio Strategies's portfolio in Q2 2026, its #734 holding.
  • Susquehanna Portfolio Strategies first reported a position in AnaptysBio in Q2 2025 and has held it in 5 quarters since.
  • Susquehanna Portfolio Strategies's AnaptysBio position peaked at $1.99M in Q1 2026.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.